CIPLA:NSE
Cipla Ltd
₹1,332.20
arrow_downward
-0.60%(-8.00) 1D
Okt 7, 2:49:32 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CIPLA...
Buksan
₹1,338.50
Mataas
₹1,351.00
Mababa
₹1,324.70
Mkt. cap
1.08T
Avg. na dami
931.46K
Dami
537.73K
Dividend
0.98%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.94
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Buksan
₹1,338.50
Mataas
₹1,351.00
Mababa
₹1,324.70
Mkt. cap
1.08T
Avg. na dami
931.46K
Dami
537.73K
Dividend
0.98%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.94
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
2 oras ang nakalipas
U.S. stock futures steady after S&P 500, Nasdaq hit records; Fed minutes awaited
The Guardian
·
12 oras ang nakalipas
S&P 500 and Nasdaq surge to record highs after AI chipmaker rally
Investor's Business Daily
·
1 buwan ang nakalipas
Dow Jones Futures: Techs Set To Run? Nvidia, CrowdStrike, Okta, Salesforce Jump On Earnings
Reuters
·
1 buwan ang nakalipas
S&P 500 to end 2026 slightly above current levels on profit optimism
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
Tungkol sa Cipla Ltd
CEOUmang Vohra
Mga Empleyado31.4K
Itinatag1935
HeadquartersMumbai, Maharashtra, India
Sektor-
Websitecipla.com